Immediate Impact
22 standout
Citing Papers
EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
2024 Standout
Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma
2024 Standout
Works of Abdullah Esmail being referenced
Association of personalized and tumor-informed ctDNA with patient survival outcomes in pancreatic adenocarcinoma.
2022
Immunotherapy as a Neoadjuvant Therapy for a Patient with Hepatocellular Carcinoma in the Pretransplant Setting: A Case Report
2022
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Abdullah Esmail | 200 | 187 | 143 | 58 | 388 | |
| Masahiro Shinoda | 153 | 158 | 83 | 43 | 342 | |
| Yuki Imaoka | 159 | 166 | 115 | 85 | 374 | |
| Eduardo A. Rodríguez | 120 | 132 | 151 | 38 | 361 | |
| Ève Simoneau | 192 | 202 | 260 | 38 | 414 | |
| Hiroaki Nagano | 104 | 129 | 187 | 41 | 370 | |
| Hirofumi Tazawa | 103 | 152 | 130 | 54 | 392 | |
| Akihiko Ichida | 116 | 193 | 264 | 49 | 384 | |
| Jiayin Yang | 118 | 189 | 325 | 27 | 424 | |
| Yusuke Iizawa | 288 | 274 | 62 | 74 | 434 | |
| Go Oshima | 177 | 243 | 104 | 37 | 361 |
All Works
Login with ORCID to disown or claim papers
Loading papers...